Rigel Pharmaceuticals Inc Net Asset Quality Index
Rigel Pharmaceuticals Inc net asset quality index. Rigel Pharmaceuticals Inc (RIGL) has a Net Asset Quality Index of 81.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $521.07 Million minus total liabilities of $95.42 Million yields net assets of $425.65 Million. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Rigel Pharmaceuticals Inc for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Rigel Pharmaceuticals Inc (1999–2025)
Net asset quality index of Rigel Pharmaceuticals Inc from 1999 to 2025. This chart shows how Rigel Pharmaceuticals Inc's Net Asset Quality Index has evolved across 27 annual periods from 1999 to 2025. As of June 2026, the index stands at 81.7%, representing net assets of $425.65 Million against total assets of $521.07 Million USD. Check Rigel Pharmaceuticals Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Rigel Pharmaceuticals Inc Net Asset Quality Index by Year (1999–2025)
Rigel Pharmaceuticals Inc net asset quality index by year from 1999 to 2025. The table below presents the year-by-year Net Asset Quality Index for Rigel Pharmaceuticals Inc from 1999 to 2025, covering 27 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Rigel Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 76.2% | $391.48 Million | $513.59 Million | $122.11 Million | ▲ +74.2 pp |
| 2024 | 2.0% | $3.29 Million | $163.98 Million | $160.69 Million | ▲ +26.4 pp |
| 2023 | -24.4% | $-28.64 Million | $117.22 Million | $145.87 Million | ▼ -14.3 pp |
| 2022 | -10.1% | $-13.62 Million | $134.28 Million | $147.90 Million | ▼ -28.3 pp |
| 2021 | 18.2% | $30.37 Million | $167.33 Million | $136.95 Million | ▼ -12.7 pp |
| 2020 | 30.8% | $34.03 Million | $110.38 Million | $76.35 Million | ▼ -5.6 pp |
| 2019 | 36.5% | $53.81 Million | $147.57 Million | $93.75 Million | ▼ -42.5 pp |
| 2018 | 79.0% | $109.88 Million | $139.11 Million | $29.23 Million | ▼ -5.5 pp |
| 2017 | 84.5% | $100.65 Million | $119.11 Million | $18.46 Million | ▲ +14.1 pp |
| 2016 | 70.4% | $55.03 Million | $78.13 Million | $23.11 Million | ▲ +1.1 pp |
| 2015 | 69.4% | $91.38 Million | $131.75 Million | $40.37 Million | ▼ -13.8 pp |
| 2014 | 83.2% | $128.25 Million | $154.13 Million | $25.89 Million | ▼ -8.9 pp |
| 2013 | 92.1% | $208.25 Million | $226.06 Million | $17.81 Million | ▼ -1.1 pp |
| 2012 | 93.2% | $289.10 Million | $310.04 Million | $20.95 Million | ▲ +1.4 pp |
| 2011 | 91.8% | $236.15 Million | $257.11 Million | $20.96 Million | ▲ +2.9 pp |
| 2010 | 89.0% | $166.13 Million | $186.69 Million | $20.56 Million | ▲ +10.9 pp |
| 2009 | 78.1% | $109.87 Million | $140.74 Million | $30.88 Million | ▲ +5.7 pp |
| 2008 | 72.4% | $104.17 Million | $143.86 Million | $39.69 Million | ▲ +1.4 pp |
| 2007 | 71.0% | $82.18 Million | $115.79 Million | $33.61 Million | ▼ -6.1 pp |
| 2006 | 77.0% | $87.23 Million | $113.24 Million | $26.01 Million | ▲ +3.5 pp |
| 2005 | 73.5% | $108.59 Million | $147.67 Million | $39.08 Million | ▲ +7.2 pp |
| 2004 | 66.4% | $52.30 Million | $78.82 Million | $26.52 Million | ▼ -5.6 pp |
| 2003 | 72.0% | $39.97 Million | $55.52 Million | $15.55 Million | ▲ +14.6 pp |
| 2002 | 57.4% | $25.44 Million | $44.34 Million | $18.90 Million | ▼ -4.9 pp |
| 2001 | 62.3% | $28.94 Million | $46.45 Million | $17.51 Million | ▼ -14.0 pp |
| 2000 | 76.3% | $49.01 Million | $64.26 Million | $15.25 Million | ▲ +71.9 pp |
| 1999 | 4.4% | $756.00K | $17.17 Million | $16.41 Million | — |